戻る Agenda
Use of Novel Trial Designs to Accelerate Decision Making: To 'P' No More
Session Chair(s)
Jonathan Haddad, MPH
HIV Disease Area Head, Clinical Statistics
GlaxoSmithKline, United States
This session will provide case studies where Bayesian statistical approaches and adaptive designs have facilitated go/no-go decisions in small proof of concept studies.
Learning Objective : Discuss Bayesian framework for decision-making; Describe early phase scenarios for adaptive trial designs.
Speaker(s)
Biomarker-Guided Adaptive Trial Designs
Nusrat Rabbee, PHD
United States
Panelist
Kert Viele, PHD
Berry Consultants, United States
Director of Research. Senior Statistical Scientist